Filed in archive
Treatment
by kevin on September 9, 2005
The FDA advisory panel endorses inhaled insulin. The FDA usually follows the recommendations of its advisory committees, but is not required to:
Millions of people with diabetes may have an alternative to some or all of their daily needles if the government adopts an advisory panel's recommendation to approve the first insulin that can be inhaled.
Federal health advisers on Thursday scrutinized the drug and inhaler device, questioning developers about the long-term effects of distributing insulin to the body through the lungs, rather than directly into the blood stream.
Proponents of the drug, Exubera, and the associated inhaler say many diabetics who refuse to take all their injections will be more inclined to use an inhaler.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/9106
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for The FDA advisory panel endorses inhaled insulin:
|
Rating: 9.00 out of 4 vote(s) cast.
|
Response from:
AmyT of www.diabetesmine.com
(09/10/05 4:32am)
Exciting, yes, but I also read that we'll have to inhale seven times as much insulin as we'd normally inject! The whole dosing issue seems problematic, no?
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
